Left ventricular hypertrophy is a leading risk factor for cardiovascular morbidity and mortality.
Although reverse ventricular remodelling was long thought to be irreversible, evidence from …

C-terminal Src kinase (CSK) is a cytosolic tyrosine-protein kinase with an important role in
regulating critical cellular decisions, such as cellular apoptosis, survival, proliferation …

Aims Identification and intervention of left ventricular hypertrophy (LVH) in essential
hypertension (EH) are important for the prevention of adverse cardiovascular events …

Sudden cardiac death due to arrhythmias, such as atrial fibrillation or ventricular
tachycardia, account for 15–20% of all deaths. Myocardial infarction increases the burden of …

BACKGROUND: Apolipoprotein (apo) E isoforms have strong correlations with metabolic
and cardiovascular diseases. However, it is not clear if apoE has a role in development of …

Fenofibrate, a PPAR-α agonist clinically used to lower serum lipid levels, reduces cardiac
remodeling and improves cardiac function. However, its mechanism of action is not …

Objective The aim of this study was to model the potential long-term disease progression
and pharmacoeconomic value of sacubitril/valsartan for the treatment of essential …

Background: The development of left ventricular hypertrophy in primary hypertension
increases cardiovascular mortality and morbidity. Reversal of left ventricular hypertrophy …

Introduction: Hyperphosphatemia in chronic kidney disease (CKD) patients can stimulate the
production of the fibroblast growth factor-23 (FGF-23) phosphatonin hormone, which is …

Although angiotensin II receptor blockers (ARBs) are more effective in women for either
reduction of blood pressure or heart failure (HF), the gender disparities and the impact of …